3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
13
Rectal Neoplasms
5
Neoplasm Metastasis
4
Cholangiocarcinoma
4
Stomach Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Biliary Tract Neoplasms
3
Adenocarcinoma Of Esophagus
3
Ovarian Neoplasms
2
Neoplasms
2
Gastrointestinal Neoplasms
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Pathologic Complete Response
1
Lung Neoplasms
1
Endometrial Neoplasms
1
Disease Progression
1
Central Nervous System Neoplasms
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Advanced Rectal Cancer
1
Adenocarcinoma of the Lower Rectum
1
Adenocarcinoma
1
Interventions
tislelizumab
4
pembrolizumab
4
Injections
4
toripalimab
3
sotorasib
1
serabelisib
1
olaparib
1
nedaplatin
1
mirdametinib
1
erdafitinib
1
envafolimab
1
darolutamide
1
atezolizumab
1
adagrasib
1
abiraterone
1
Taxes
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fulvestrant
1
Drug Therapy
1
CD3 Complex
1
Bevacizumab
1
Antineoplastic Agents
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
Folfox protocol
×
90 days
×
Clear all
No trials found.